Replies to post #251 on KalVista Pharmaceuticals (KALV)

[Toxic Avenger]

The market isn't that stupid. It's a terrible deal. Selling 80% of $40 million plus in cash for some future prospects.

But the deal needs to be voted on and hopefully gets voted down.

Liquidate the company - stockholders would do better, only senior execs lose out as they can't keep their jobs.